Haemophilus influenzae and the complement system

Trends in Microbiology

Volumn 18, Issue 6, 2010, Pages 258-265

  Hallström, Teresia ^a,b   Riesbeck, Kristian ^a  

^a LUND UNIVERSITY   (Sweden)

^b HANS KNÖLL INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL POLYSACCHARIDE; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C5B; LECTIN; LIPOOLIGOSACCHARIDE; OUTER MEMBRANE PROTEIN; PHOSPHORYLCHOLINE; SIALIC ACID; VITRONECTIN; BACTERIUM ANTIBODY; COMPLEMENT; LIPID LINKED OLIGOSACCHARIDES; LIPID-LINKED OLIGOSACCHARIDES; LIPOPOLYSACCHARIDE; MEMBRANE ANTIGEN;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL OUTER MEMBRANE; COMPLEMENT SYSTEM; ENZYME DEGRADATION; HAEMOPHILUS INFLUENZAE; HOST RESISTANCE; INNATE IMMUNITY; LIPOLYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE; RESPIRATORY SYSTEM; COMPLEMENT ACTIVATION; HAEMOPHILUS INFECTION; HUMAN; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MUCOSA; PATHOGENICITY; RESPIRATORY TRACT INFECTION; REVIEW;

BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE;

ANTIBODIES, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL CAPSULES; BACTERIAL OUTER MEMBRANE PROTEINS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; IMMUNE EVASION; LIPOPOLYSACCHARIDES; MUCOUS MEMBRANE; POLYSACCHARIDES, BACTERIAL; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS;

EID: 78049490091     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2010.03.007     Document Type: Review

References (74)

1. Watt, J.P. et al. (2009) Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 374, 903-911
2. Morris, S.K. et al. (2008) Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect. Dis. 8, 435-443
3. Adderson, E.E. et al. (2001) Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era? Pediatrics 108, E18
4. Brown, V.M. et al. (2009) Invasive Haemophilus influenzae disease caused by non-type b strains in Northwestern Ontario, Canada, 2002-2008. Clin. Infect. Dis. 49, 1240-1243
5. Bruce, M.G. et al. (2008) Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000-2005. Emerg. Infect. Dis 14, 48-55
6. Tsang, R.S. et al. (2007) Characterization of invasive Haemophilus influenzae disease in Manitoba, Canada, 2000-2006: invasive disease due to non-type b strains. Clin. Infect. Dis 44, 1611-1614
7. Erwin, A.L. and Smith, A.L. (2007) Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior. Trends. Microbiol. 15, 355-362
8. Murphy, T.F. et al. (2009) Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr. Infect. Dis. J. 28, 43-48
9. Murphy, T.F. (2006) The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr. Opin. Infect. Dis. 19, 225-230
10. Vergison, A. (2008) Microbiology of otitis media: a moving target. Vaccine 26 (Suppl 7), G5-10
11. Bajanca, P. and Canica, M. (2004) Emergence of nonencapsulated and encapsulated non-b-type invasive Haemophilus influenzae isolates in Portugal (1989-2001). J. Clin. Microbiol. 42, 807-810
12. Dworkin, M.S. et al. (2007) The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or = 65 years old. Clin. Infect. Dis. 44, 810-816
13. Ulanova, M. and Tsang, R.S. (2009) Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century. Infect. Genet. Evol. 9, 594-605
14. Walport, M.J. (2001) Complement. First of two parts. N. Engl. J. Med. 344, 1058-1066
15. Zhang, X.L. and Ali, M.A. (2008) Ficolins: structure, function and associated diseases. Adv. Exp. Med. Biol. 632, 105-115
16. Gal, P. et al. (2009) Early complement proteases: C1r, C1s and MASPs. A structural insight into activation and functions. Mol. Immunol. 46, 2745-2752
17. Zipfel, P.F. and Skerka, C. (2009) Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9, 729-740
18. Blom, A.M. et al. (2004) Complement inhibitor C4b-binding protein - friend or foe in the innate immune system? Mol. Immunol. 40, 1333- 1346
19. Jozsi, M. and Zipfel, P.F. (2008) Factor H family proteins and human diseases. Trends. Immunol. 29, 380-387
20. Heinen, S. et al. (2009) Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 114, 2439-2447
21. Greiff, L. et al. (2003) Airway microvascular extravasation and luminal entry of plasma. Clin. Physiol. Funct. Imaging 23, 301-306
22. Persson, C.G. et al. (1991) Plasma exudation as a first line respiratory mucosal defence. Clin. Exp. Allergy 21, 17-24
23. Marc, M.M. et al. (2004) Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma. Am. J. Respir. Cell. Mol. Biol. 31, 216-219
24. Nörkiö-Mökelö, M. et al. (2001) Complement-regulator factor H and related proteins in otitis media with effusion. Clin. Immunol. 100, 118- 126
25. Nörkiö-Mökelö, M. et al. (2000) Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion. Laryngoscope 110, 1745-1749
26. Van Zele, T. et al. (2009) Local complement activation in nasal polyposis. Laryngoscope 119, 1753-1758
27. Andersson, M. et al. (1994) Complement activation on the nasal mucosal surface - a feature of the immediate allergic reaction in the nose. Allergy 49, 242-245
28. Bjornson, A.B. et al. (1991) Complement is activated in the upper respiratory tract during influenza virus infection. Am. Rev. Respir. Dis. 143, 1062-1066
29. Blom, A.M. et al. (2009) Complement evasion strategies of pathogens - acquisition of inhibitors and beyond. Mol. Immunol. 46, 2808-2817
30. Lambris, J.D. et al. (2008) Complement evasion by human pathogens. Nat. Rev. Microbiol. 6, 132-142
31. Williams, B.J. et al. (2001) Serum resistance in an invasive, nontypeable Haemophilus influenzae strain. Infect. Immun. 69, 695- 705
32. Porto, M.H. et al. (1989) Resistance to serum bactericidal activity distinguishes Brazilian purpuric fever (BPF) case strains of Haemophilus influenzae biogroup aegyptius (H. aegyptius) from non-BPF strains. Brazilian Purpuric Fever Study Group. J. Clin.Microbiol. 27, 792-794
33. Tan, T.T. et al. (2007) Haemophilus influenzae survival during complement-mediated attacks is promoted by Moraxella catarrhalis outer membrane vesicles. J. Infect. Dis. 195, 1661-1670
34. Tedesco, F. (2008) Inherited complement deficiencies and bacterial infections. Vaccine 26 (Suppl 8), I3-8
35. Pittman, M. (1931) Variation and type specificity in the bacterial species Haemophilus influenzae. J. Exp. Med. 53, 471-492
36. Sukupolvi-Petty, S. et al. (2006) The Haemophilus influenzae type b hcsA and hcsB gene products facilitate transport of capsular polysaccharide across the outer membrane and are essential for virulence. J. Bacteriol. 188, 3870-3877
37. Sutton, A. et al. (1982) Differential complement resistance mediates virulence of Haemophilus influenzae type b. Infect. Immun. 35, 95-104
38. Hoiseth, S.K. et al. (1986) Genes involved in Haemophilus influenzae type b capsule expression are part of an 18-kilobase tandem duplication. Proc. Natl. Acad. Sci. U. S. A. 83, 1106-1110
39. Corn, P.G. et al. (1993) Genes involved in Haemophilus influenzae type b capsule expression are frequently amplified. J. Infect. Dis. 167, 356- 364
40. Noel, G.J. et al. (1996) Effect of amplification of the Cap b locus on complement-mediated bacteriolysis and opsonization of type b Haemophilus influenzae. Infect. Immun. 64, 4769-4775
41. Noel, G.J. et al. (1992) Type b capsule inhibits ingestion of Haemophilus influenzae by murine macrophages: studies with isogenic encapsulated and unencapsulated strains. J. Infect. Dis. 166, 178-182
42. Swift, A.J. et al. (1991) Complement-mediated serum activities against genetically defined capsular transformants of Haemophilus influenzae. Microb. Pathog. 10, 261-269
43. Moxon, E.R. (2009) Bacterial variation, virulence and vaccines. Microbiology 155, 997-1003
44. Erwin, A.L. et al. (2006) Role of lgtC in resistance of nontypeable Haemophilus influenzae strain R2866 to human serum. Infect. Immun. 74, 6226-6235
45. Ho, D.K. et al. (2007) lgtC expression modulates resistance to C4b deposition on an invasive nontypeable Haemophilus influenzae. J. Immunol. 178, 1002-1012
46. Erwin, A.L. et al. (2006) Heterogeneity in tandem octanucleotides within Haemophilus influenzae lipopolysaccharide biosynthetic gene losA affects serum resistance. Infect. Immun. 74, 3408- 3414
47. Erwin, A.L. et al. (2005) Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus influenzae. Infect. Immun. 73, 5853-5863
48. Griffin, R. et al. (2005) Elucidation of the monoclonal antibody 5G8-reactive, virulence-associated lipopolysaccharide epitope of Haemophilus influenzae and its role in bacterial resistance to complement-mediated killing. Infect. Immun. 73, 2213-2221
49. Weiser, J.N. et al. (1998) Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killingmediated by C-reactive protein. J. Exp. Med. 187, 631-640
50. Fox, K.L. et al. (2008) Duplicate copies of lic1 direct the addition of multiple phosphocholine residues in the lipopolysaccharide of Haemophilus influenzae. Infect. Immun. 76, 588-600
51. Harvey, H.A. et al. (2001) The mimicry of human glycolipids and glycosphingolipids by the lipooligosaccharides of pathogenic Neisseria and Haemophilus. J. Autoimmun. 16, 257-262
52. Figueira,M.A. et al. (2007) Role of complement in defense of themiddle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants. Infect. Immun. 75, 325-333
53. Hood, D.W. et al. (2001) Identification of a lipopolysaccharide alpha-2,3-sialyltransferase from Haemophilus influenzae. Mol. Microbiol. 39, 341-350
54. Allen, S. et al. (2005) Novel sialic acid transporter of Haemophilus influenzae. Infect. Immun. 73, 5291-5300
55. Severi, E. et al. (2005) Sialic acid transport in Haemophilus influenzae is essential for lipopolysaccharide sialylation and serum resistance and is dependent on a novel tripartite ATP-independent periplasmic transporter. Mol. Microbiol. 58, 1173-1185
56. Jenkins, G.A. et al. (2010) Sialic acid mediated transcriptional modulation of a highly conserved sialometabolism gene cluster in Haemophilus influenzae and its effect on virulence. BMC Microbiol. 10, 48
57. Bouchet, V. et al. (2003) Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media. Proc. Natl. Acad. Sci. U. S. A. 100, 8898-8903
58. Forbes, K.J. et al. (1992) Variation in length and sequence of porin (ompP2) alleles of non-capsulate Haemophilus influenzae. Mol. Microbiol. 6, 2107-2112
59. Ostberg, K.L. et al. (2009) Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae. Mucosal Immunol. 2, 63-73
60. Murphy, T.F. et al. (2006) Construction of a mutant and characterization of the role of the vaccine antigen P6 in outer membrane integrity of nontypeable Haemophilus influenzae. Infect. Immun. 74, 5169-5176
61. De Souza-Hart, J.A. et al. (2003) Two-component systems in Haemophilus influenzae: a regulatory role for ArcA in serum resistance. Infect. Immun. 71, 163-172
62. Miyazaki, S. et al. (1999) The pathogenic role of fimbriae of Haemophilus influenzae type b in murine bacteraemia and meningitis. J. Med. Microbiol. 48, 383-388
63. Hallström, T. et al. (2009) Nontypeable Haemophilus influenzae protein E binds vitronectin and is important for serum resistance. J. Immunol. 183, 2593-2601
64. Hallström, T. et al. (2006) Haemophilus influenzae surface fibrils contribute to serum resistance by interacting with vitronectin. J. Immunol. 177, 430-436
65. Hallström, T. et al. (2007) Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance. J. Immunol. 178, 6359-6366
66. Hallström, T. et al. (2008) Haemophilus influenzae interacts with the human complement inhibitor factor H. J. Immunol. 181, 537-545
67. Eberhard, T. and Ullberg, M. (2002) Interaction of vitronectin with Haemophilus influenzae. FEMS Immunol. Med. Microbiol. 34, 215-219
68. Ronander, E. et al. (2008) Identification of a novel Haemophilus influenzae protein important for adhesion to epithelial cells. Microbes. Infect. 10, 87-96
69. Ronander, E. et al. (2009) Nontypeable Haemophilus influenzae adhesin protein E: characterization and biological activity. J. Infect. Dis. 199, 522-531
70. Singh, B. et al. (2010) Protein E of Haemophilus influenzae is a ubiquitous highly conserved adhesin. J. Infect. Dis. 201, 414-419
71. Hallström, T. et al. (2010) Binding of complement regulators to invasive nontypeable Haemophilus influenzae is not increased compared to nasopharyngeal isolates, but serum resistance is linked to disease severity. J. Clin. Microbiol. 48, 921-927
72. Sethi, S. and Murphy, T.F. (2008) Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 359, 2355-2365
73. Block, S.L. et al. (2004) Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr. Infect. Dis. J. 23, 829-833
74. Meri, S. et al. (2008) Microbial complement inhibitors as vaccines. Vaccine 26 (Suppl 8), I113-117